|
SNAPC3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.416290E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.347400E-01 |
| Normal-vs-Stage2 |
7.954600E-01 |
| Normal-vs-Stage3 |
1.74365999999759E-05 |
| Normal-vs-Stage4 |
2.18439999999376E-05 |
| Stage1-vs-Stage2 |
7.329600E-01 |
| Stage1-vs-Stage3 |
4.97430000001575E-06 |
| Stage1-vs-Stage4 |
1.66803999999132E-05 |
| Stage2-vs-Stage3 |
1.417860E-03 |
| Stage2-vs-Stage4 |
1.199980E-03 |
| Stage3-vs-Stage4 |
6.116800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.405800E-02 |
| Normal-vs-AfricanAmerican |
1.930560E-01 |
| Normal-vs-Asian |
7.624000E-01 |
| Caucasian-vs-AfricanAmerican |
9.765200E-01 |
| Caucasian-vs-Asian |
3.710400E-01 |
| AfricanAmerican-vs-Asian |
4.215800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.238100E-04 |
| Normal-vs-Female |
9.372400E-01 |
| Male-vs-Female |
1.276110E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.722000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.893000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.600510E-03 |
| Normal-vs-Age(81-100Yrs) |
7.247800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.357600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.596200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.274400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.740500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.884800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.129800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.549880E-02 |
| Normal-vs-Grade 2 |
8.400400E-01 |
| Normal-vs-Grade 3 |
1.916860E-03 |
| Normal-vs-Grade 4 |
6.51939946472169E-10 |
| Grade 1-vs-Grade 2 |
9.299200E-03 |
| Grade 1-vs-Grade 3 |
1.034500E-04 |
| Grade 1-vs-Grade 4 |
2.52880000273237E-08 |
| Grade 2-vs-Grade 3 |
8.844700E-04 |
| Grade 2-vs-Grade 4 |
9.10080011351511E-10 |
| Grade 3-vs-Grade 4 |
1.373600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.798700E-03 |
| Normal-vs-ccB subtype |
8.42390002198101E-09 |
| ccA subtype-vs-ccB subtype |
1.11022302462516E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.285800E-02 |
| Normal-vs-N1 |
3.32629999988399E-07 |
| N0-vs-N1 |
7.235000E-03 |
|
|
